Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarizax for HDM Allergic Rhinitis (QUEST)
NCT04176185Phase 3Terminated
- Sponsor
- ALK-Abelló
- Start
- Nov 2019
- Primary completion
- Dec 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of SQ SLIT-tablet in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Nov 2019; status: terminated.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT04176185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176185.